4th Circ. Denies Eli Lilly's Discovery Bid In Novartis IP Feud
By Jasmin Boyce · June 16, 2022, 8:53 PM EDT
The Fourth Circuit on Thursday affirmed a Virginia district court's decision denying Eli Lilly's discovery bid related to Novartis' European patent suit over Eli Lilly's psoriasis drug Taltz, agreeing that Novartis...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login